US · Healthcare · Biotechnology
EPS came in at -0.29 against a street estimate of -0.48 — a beat of 39.6%.
Analysts rate Septerna, Inc. Common Stock a buy (3 buy, 1 hold, 0 sell out of 4) with an average price target of $54.22.
| Fund | Stake |
|---|---|
| RA Capital Management, LLC | 14.99% |
| TRV GP V, LLC | 13.32% |
| Driehaus Capital Management LLC | 9.42% |
| TRV GP VI, LLC | 9.02% |
| Samsara BioCapital, LLC | 6.75% |
| The Goldman Sachs Group Inc | 6.23% |
| Siren, L.L.C. | 4.28% |
| BlackRock Inc | 3.90% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 SEPTERNA, INC. (SEPN) - 8-K SUMMARY BUSINESS & SEGMENT HIGHLIGHTS • Company appointed Rajiv Patni, M.D., as Chief Medical Officer effective August 2 | 2026-08-25 |
| Quarterly report · Q2 2026 SEPTERNA, INC. – Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash and equivalents: $84.7 million (June 30, 2026) vs. $120.7 million (Dec 31, 2025) — dow | 2026-08-10 |
| Results announced · Q3 2026 SEPTERNA, INC. — Q2 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Cash Position: $516.5 million in cash, cash equivalents, and marketable securities as | 2026-08-10 |
| Shareholder vote results · Q2 2026 SEPTERNA, INC. (NASDAQ: SEPN) – 8-K SUMMARY HEADLINE NUMBERS • Annual shareholder meeting held June 26, 2026 • Total votes cast for Class II directo | 2026-06-30 |
| Quarterly report · Q1 2026 SEPTERNA, INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Cash and equivalents: $71.6 million as of March 31, 2026 (down from $120.7 million at Decem | 2026-05-11 |
| Results announced · Q2 2026 SEPTERNA, INC. — Q1 2026 FINANCIAL SUMMARY HEADLINE NUMBERS • Cash position: $522.1 million as of March 31, 2026 (down from $548.7 million at Decemb | 2026-05-11 |
| Proxy statement · Q2 2026 SEPTERNA, INC. — 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1: Elect two Class II directors to serve until the 2029 Ann | 2026-04-30 |
| Annual report FY2025 SEPTERNA, INC. – 10-K SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Market Capitalization (as of June 30, 2025): $363.3 million (based on $10.57 p | 2026-03-09 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Septerna, Inc. Common Stock — free to start.
Google PlayApp StoreData updated 2026-09-18.